Clinical Trial Update: Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461 [Phase 1]

View source ↗

Summary

This Phase 1 study update reports safety, tolerability, and preliminary pharmacokinetic and pharmacodynamic data for mavacamten (MYK-461) in patients with hyper…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Drugs mentioned

• MYK-461 (mavacamten)

Snippet

Sponsor: MyoKardia, Inc. | Conditions: Hypertrophic Cardiomyopathy | Phase 1 | Status: COMPLETED